The Europe Smart Inhalers Market would witness market growth of 24.0% CAGR during the forecast period (2021-2027).
The devices that have been created so far appear to function with a wide range of inhalers. it is known that individuals with asthma may need to move between inhalers, therefore it's critical that as these are launched, people with asthma can effortlessly switch between treatments while still using a smart inhaler. Bluetooth is used to connect the devices to cell phones. Each manufacturer typically has a smartphone app that allows the user to view their data or adjust their reminder settings, although these apps may not be accessible for all smartphone models. So far, the smart inhaler apps that have surfaced appear to function on both iPhone and Android devices.
Digital medicines are the wave of the future, allowing for even more personalization of chronic illness management as well as unmatched patient health and treatment adherence monitoring. Patients with asthma or COPD can use digital inhalers to gain more control over their condition, identify triggers, connect and share information with their doctors, and collect valuable research data. By establishing pertinent alerts or notifications, the technology is a great tool for facilitating adherence to treatment schedules, dosage reminders, and tracking inhaler usage. Some digital inhalers may even detect and alarm patients if they fail to carry their gadgets with them or track excessive levels of pollution or pollen
The expansion of the smart inhalers market in Europe is attributed to the increased acceptance of smart inhalation devices and increasing demands for digital medical devices in Germany, the United Kingdom, and France, owing to a need to improve the patient experience. The presence of significant suppliers operating in the European market also contributes to the high growth rate.
Asthma impacted over 6% of the EU population in 2019, a minor rise from 2014 (+0.3%). Finland topped the list among EU countries, with 9% of the population reporting asthma, followed by Germany and France (both 8%). In Romania and Bulgaria, however, only 2% of the population reported having this condition. In 2019, the number of people reporting asthma increased the highest in Germany (+1.9%), Croatia (+1.8%), and Belgium (+1.5%) compared to 2014. On the other hand, Ireland (-1.7%), Greece (-1.1%), and France (1.0 percentage point) saw the greatest decline in the number of patients reporting this disease.
The Germany market dominated the Europe Smart Inhalers Market by Country in 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $27,184 Thousands by 2027. The UK market is experiencing a CAGR of 23.1% during (2021 - 2027). Additionally, The France market would witness a CAGR of 25% during (2021 - 2027).
Based on Product, the market is segmented into Metered Dose Inhalers (MDI's), and Dry Powdered Inhalers (DPIs). Based on Disease Indication, the market is segmented into Asthma, and Chronic Obstructive Pulmonary Disease (COPD). Based on Distribution Channel, the market is segmented into Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Smart Inhalers Market Size will Hit $414.4 Million by 2027, at a CAGR of 24.9%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Adherium Limited, Aptar Group Inc. (Cohero Health Inc.), AstraZeneca, Inc., Cognita Labs, LLC, GlaxoSmithKline Plc, Novartis AG, OPKO Health, Inc., Philip Morris International, Inc. (Vectura Group Plc), Resmed, Inc. (Propeller Health), and Teva Pharmaceutical Industries Ltd.
Scope of the Study
Market Segments Covered in the Report:
By Product
- Metered Dose Inhalers (MDI's)
- Dry Powdered Inhalers (DPIs)
By Disease Indication
- Asthma
- Chronic Obstructive Pulmonary Disease (COPD)
By Distribution Channel
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Adherium Limited
- Aptar Group Inc. (Cohero Health Inc.)
- AstraZeneca, Inc.
- Cognita Labs, LLC
- GlaxoSmithKline Plc
- Novartis AG
- OPKO Health, Inc.
- Philip Morris International, Inc. (Vectura Group Plc)
- Resmed, Inc. (Propeller Health)
- Teva Pharmaceutical Industries Ltd.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Smart Inhalers Market, by Product
1.4.2 Europe Smart Inhalers Market, by Disease Indication
1.4.3 Europe Smart Inhalers Market, by Distribution Channel
1.4.4 Europe Smart Inhalers Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
Chapter 4. Europe Smart Inhalers Market by Product
4.1 Europe Metered Dose Inhalers (MDI's) Market by Country
4.2 Europe Dry Powdered Inhalers (DPIs) Market by Country
Chapter 5. Europe Smart Inhalers Market by Disease Indication
5.1 Europe Asthma Market by Country
5.2 Europe Chronic Obstructive Pulmonary Disease (COPD) Market by Country
Chapter 6. Europe Smart Inhalers Market by Distribution Channel
6.1 Europe Hospitals Pharmacies Market by Country
6.2 Europe Retail Pharmacies Market by Country
6.3 Europe Online Pharmacies Market by Country
Chapter 7. Europe Smart Inhalers Market by Country
7.1 Germany Smart Inhalers Market
7.1.1 Germany Smart Inhalers Market by Product
7.1.2 Germany Smart Inhalers Market by Disease Indication
7.1.3 Germany Smart Inhalers Market by Distribution Channel
7.2 UK Smart Inhalers Market
7.2.1 UK Smart Inhalers Market by Product
7.2.2 UK Smart Inhalers Market by Disease Indication
7.2.3 UK Smart Inhalers Market by Distribution Channel
7.3 France Smart Inhalers Market
7.3.1 France Smart Inhalers Market by Product
7.3.2 France Smart Inhalers Market by Disease Indication
7.3.3 France Smart Inhalers Market by Distribution Channel
7.4 Russia Smart Inhalers Market
7.4.1 Russia Smart Inhalers Market by Product
7.4.2 Russia Smart Inhalers Market by Disease Indication
7.4.3 Russia Smart Inhalers Market by Distribution Channel
7.5 Spain Smart Inhalers Market
7.5.1 Spain Smart Inhalers Market by Product
7.5.2 Spain Smart Inhalers Market by Disease Indication
7.5.3 Spain Smart Inhalers Market by Distribution Channel
7.6 Italy Smart Inhalers Market
7.6.1 Italy Smart Inhalers Market by Product
7.6.2 Italy Smart Inhalers Market by Disease Indication
7.6.3 Italy Smart Inhalers Market by Distribution Channel
7.7 Rest of Europe Smart Inhalers Market
7.7.1 Rest of Europe Smart Inhalers Market by Product
7.7.2 Rest of Europe Smart Inhalers Market by Disease Indication
7.7.3 Rest of Europe Smart Inhalers Market by Distribution Channel
Chapter 8. Company Profiles
8.1 Adherium Limited
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Product Launches and Product Expansions:
8.1.5.2 Approvals and Trials:
8.2 GlaxoSmithKline PLC (GSK)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.3 Teva Pharmaceutical Industries Ltd.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Product Launches and Product Expansions:
8.4 AstraZeneca PLC
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Approvals and Trials:
8.5 OPKO Health, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.6 Aptar Group, Inc. (Cohero Health Inc.)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Product Launches and Product Expansions:
8.7 Novartis AG
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Approvals and Trials:
8.8 ResMed, Inc. (Propeller Health)
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent strategies and developments:
8.8.5.1 Acquisition and Mergers:
8.9 Cognita Labs, LLC
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Approvals and Trials:
8.10. Vectura Group plc (Philip Morris International, Inc.)
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expenses
TABLE 1 Europe Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 2 Europe Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 3 Partnerships, Collaborations and Agreements– Smart Inhalers Market
TABLE 4 Product Launches And Product Expansions– Smart Inhalers Market
TABLE 5 Acquisition and Mergers– Smart Inhalers Market
TABLE 6 Approvals and trials- smart inhalers market
TABLE 7 Europe Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 8 Europe Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 9 Europe Metered Dose Inhalers (MDI's) Market by Country, 2017 - 2020, USD Thousands
TABLE 10 Europe Metered Dose Inhalers (MDI's) Market by Country, 2021 - 2027, USD Thousands
TABLE 11 Europe Dry Powdered Inhalers (DPIs) Market by Country, 2017 - 2020, USD Thousands
TABLE 12 Europe Dry Powdered Inhalers (DPIs) Market by Country, 2021 - 2027, USD Thousands
TABLE 13 Europe Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 14 Europe Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 15 Europe Asthma Market by Country, 2017 - 2020, USD Thousands
TABLE 16 Europe Asthma Market by Country, 2021 - 2027, USD Thousands
TABLE 17 Europe Chronic Obstructive Pulmonary Disease (COPD) Market by Country, 2017 - 2020, USD Thousands
TABLE 18 Europe Chronic Obstructive Pulmonary Disease (COPD) Market by Country, 2021 - 2027, USD Thousands
TABLE 19 Europe Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 20 Europe Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 21 Europe Hospitals Pharmacies Market by Country, 2017 - 2020, USD Thousands
TABLE 22 Europe Hospitals Pharmacies Market by Country, 2021 - 2027, USD Thousands
TABLE 23 Europe Retail Pharmacies Market by Country, 2017 - 2020, USD Thousands
TABLE 24 Europe Retail Pharmacies Market by Country, 2021 - 2027, USD Thousands
TABLE 25 Europe Online Pharmacies Market by Country, 2017 - 2020, USD Thousands
TABLE 26 Europe Online Pharmacies Market by Country, 2021 - 2027, USD Thousands
TABLE 27 Europe Smart Inhalers Market by Country, 2017 - 2020, USD Thousands
TABLE 28 Europe Smart Inhalers Market by Country, 2021 - 2027, USD Thousands
TABLE 29 Germany Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 30 Germany Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 31 Germany Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 32 Germany Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 33 Germany Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 34 Germany Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 35 Germany Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 36 Germany Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 37 UK Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 38 UK Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 39 UK Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 40 UK Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 41 UK Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 42 UK Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 43 UK Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 44 UK Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 45 France Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 46 France Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 47 France Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 48 France Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 49 France Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 50 France Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 51 France Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 52 France Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 53 Russia Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 54 Russia Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 55 Russia Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 56 Russia Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 57 Russia Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 58 Russia Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 59 Russia Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 60 Russia Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 61 Spain Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 62 Spain Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 63 Spain Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 64 Spain Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 65 Spain Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 66 Spain Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 67 Spain Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 68 Spain Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 69 Italy Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 70 Italy Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 71 Italy Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 72 Italy Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 73 Italy Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 74 Italy Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 75 Italy Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 76 Italy Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 77 Rest of Europe Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 78 Rest of Europe Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 79 Rest of Europe Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 80 Rest of Europe Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 81 Rest of Europe Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 82 Rest of Europe Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 83 Rest of Europe Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 84 Rest of Europe Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 85 Key Information – Adherium Limited
TABLE 86 Key Information – GlaxoSmithKline PLC (GSK)
TABLE 87 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 88 KEY INFORMATION – ASTRAZENECA PLC
TABLE 89 Key Information – OPKO Health, Inc.
TABLE 90 key Information – Aptar Group, Inc.
TABLE 91 Key Information – Novartis AG
TABLE 92 Key Information – ResMed, Inc.
TABLE 93 Key Information – Cognita Labs, LLC
TABLE 94 Key Information – Vectura Group plc
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Recent strategies and developments: Adherium Limited
FIG 4 Recent strategies and developments: AptarGroup, Inc.